Search research articles
Contact Us
Filters
Showing results (91-100 of 143) with videos related to
Page
of 15
Sort By:
Journal of Virological Methods
|
August 3, 2025
Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
Kiho Tanaka, Youry Kim, Jesslyn Ong, et al.
The Journal of Biological Chemistry
|
April 8, 2010
X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells
Kate L Jones, Michael Roche, Michael P Gantier, et al.
Viruses
|
February 13, 2014
Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains
Jacqueline K Flynn, Geza Paukovics, Kieran Cashin, et al.
Virology
|
January 11, 2011
CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity
Jasminka Sterjovski, Melissa J Churchill, Michael Roche, et al.
Antiviral Research
|
June 21, 2025
Host-directed approaches in the pursuit of a cure for HIV
Rory A Shepherd, Kiho Tanaka, Hannah A D King, et al.
Journal of Virology
|
August 13, 2011
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages
Kieran Cashin, Michael Roche, Jasminka Sterjovski, et al.
Retrovirology
|
November 8, 2011
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
Michael Roche, Martin R Jakobsen, Anne Ellett, et al.
Retrovirology
|
September 18, 2013
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
Kieran Cashin, Martin R Jakobsen, Jasminka Sterjovski, et al.
Retrovirology
|
November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc
Katharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
Journal of Virus Eradication
|
July 13, 2023
Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
Carolin Tumpach, Catherine R Cochrane, Youry Kim, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 143) with videos related to
Sort By:
Page
of 15
Journal of Virological Methods
|
August 3, 2025
Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
Kiho Tanaka, Youry Kim, Jesslyn Ong, et al.
The Journal of Biological Chemistry
|
April 8, 2010
X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells
Kate L Jones, Michael Roche, Michael P Gantier, et al.
Viruses
|
February 13, 2014
Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains
Jacqueline K Flynn, Geza Paukovics, Kieran Cashin, et al.
Virology
|
January 11, 2011
CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity
Jasminka Sterjovski, Melissa J Churchill, Michael Roche, et al.
Antiviral Research
|
June 21, 2025
Host-directed approaches in the pursuit of a cure for HIV
Rory A Shepherd, Kiho Tanaka, Hannah A D King, et al.
Journal of Virology
|
August 13, 2011
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages
Kieran Cashin, Michael Roche, Jasminka Sterjovski, et al.
Retrovirology
|
November 8, 2011
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
Michael Roche, Martin R Jakobsen, Anne Ellett, et al.
Retrovirology
|
September 18, 2013
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
Kieran Cashin, Martin R Jakobsen, Jasminka Sterjovski, et al.
Retrovirology
|
November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc
Katharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
Journal of Virus Eradication
|
July 13, 2023
Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
Carolin Tumpach, Catherine R Cochrane, Youry Kim, et al.
Page
of 15